Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity
Autor: | Kelsey Jacobson, M. Walker, M. Gueber-Xabier, Alyse D. Portnoff, Greg Glenn, Larry Ellingsworth, Jing-Hui Tian, Gale Smith, N. Natel, Mike Massare, Rhonda Flores |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
respiratory syncytial virus Immunology Mutant lcsh:Medicine Biology Article Epitope Virus 03 medical and health sciences 0302 clinical medicine Antigen Drug Discovery Pharmacology (medical) prefusogenic RSV F 030212 general & internal medicine Integral membrane protein Pharmacology chemistry.chemical_classification Immunogenicity lcsh:R cotton rat fusion glycoprotein Virology 030104 developmental biology Infectious Diseases Immunization chemistry biology.protein Antibody Glycoprotein |
Zdroj: | Vaccines, Vol 8, Iss 607, p 607 (2020) Vaccines Volume 8 Issue 4 |
ISSN: | 2076-393X |
DOI: | 10.3390/vaccines8040607 |
Popis: | Human respiratory syncytial virus (RSV) is a cause of lower respiratory tract infection in infants, young children, and older adults. There is no licensed vaccine and prophylactic treatment options are limited. The RSV fusion (F) glycoprotein is a target of host immunity and thus a focus for vaccine development. F-trimers are metastable and undergo significant rearrangements from the prefusion to a stable postfusion structure with neutralizing epitopes on intermediate structures. We hypothesize that vaccine strategies that recapitulate the breathable F quaternary structure, and provide accessibility of B-cells to epitopes on intermediate conformations, may collectively contribute to protective immunity, while rigid prefusion F structures restrict access to key protective epitopes. To test this hypothesis, we used the near full-length prefusogenic F as a backbone to construct three prefusion F variants with substitutions in the hydrophobic head cavity: (1) disulfide bond mutant (DS), (2) space filling hydrophobic amino acid substitutions (Cav1), and (3) DS, Cav1 double mutant (DS-Cav1). In this study, we compared the immunogenicity of prefusogenic F to prefusion F variants in two animal models. Native prefusogenic F was significantly more immunogenic, producing high titer antibodies to prefusogenic, prefusion, and postfusion F structures, while animals immunized with DS or DS-Cav1 produced antibodies to prefusion F. Importantly, prefusogenic F elicited antibodies that target neutralizing epitopes including prefusion-specific site zero (Ø ) and V and conformation-independent neutralizing sites II and IV. Immunization with DS or DS-Cav1 elicited antibodies primarily to prefusion-specific sites Ø and V with little or no antibodies to other key neutralizing sites. Animals immunized with prefusogenic F also had significantly higher levels of antibodies that cross-neutralized RSV A and B subtypes, while immunization with DS or DS-Cav1 produced antibodies primarily to the A subtype. We conclude that breathable trimeric vaccines that closely mimic the native F-structure, and incorporate strategies for B-cell accessibility to protective epitopes, are important considerations for vaccine design. F structures locked in a single conformation restrict access to neutralizing epitopes that may collectively contribute to destabilizing F-trimers important for broad protection. These results also have implications for vaccine strategies targeting other type 1 integral membrane proteins. |
Databáze: | OpenAIRE |
Externí odkaz: |